Riskpilot← Back to searchSign inGet full accessAXONKLINIKKEN AS
ASActiveOrg 921108338Bogstadveien 11, 0355 OsloOther human health activities n.e.c. · NACE 8699Est. 201815 employeeswww.axon.no
Revenue 2024
NOK 16,2M
+91% vs 2023
EBITDA margin
-26.7%
+40% vs 2023
Equity ratio
-90.9%
Financial strength
Net profit 2024
NOK -4,8M
+35% vs 2023
| Revenue | NOK 16,2M | +91% |
| EBITDA | NOK -4,3M | +40% |
| Net profit | NOK -4,8M | +35% |
| Total assets | NOK 5,1M | +33% |
| Equity | NOK -4,7M | -8047% |
| Employees | 15 | — |
Legal name
AXONKLINIKKEN AS
Org number
921108338
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
3. juli 2018
Share capital
NOK 4 418 270
Employees
15 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Helsetjenester samt det som naturlig står i forbindelse med dette.
Address
Bogstadveien 11, 0355 Oslo
Phone
+4721403819
Email
kontakt@axonklinikken.no
Website
www.axon.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 772 | 3 402 | 4 232 | 8 520 | 16 240 |
| Staff expenses | −1 265 | −2 191 | −6 446 | −9 460 | −11 842 |
| EBITDA | 143 | −75 | −4 446 | −7 198 | −4 344 |
| Depreciation & amort. | −0 | −39 | −51 | −284 | −291 |
| EBIT | 143 | −114 | −4 497 | −7 482 | −4 635 |
| Net financials | −3 | −2 | −61 | 22 | −189 |
| Profit before tax | 141 | −116 | −4 558 | −7 460 | −4 824 |
| Tax | 31 | −0 | −0 | −0 | −0 |
| Net profit | 110 | −116 | −4 558 | −7 460 | −4 824 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 610 | 909 | 5 612 | 3 868 | 5 126 |
| Equity | 354 | 237 | −4 321 | −57 | −4 658 |
| Long-term debt | 0 | 0 | 4 490 | 0 | 5 746 |
| Short-term debt | 257 | 672 | 5 444 | 3 926 | 4 037 |
| Total debt | 257 | 672 | 9 934 | 3 926 | 9 784 |
EBITDA margin
-26.7%
This company
15.8%
Market median
-269% vs market
20202024
Equity ratio
-90.9%
This company
38.2%
Market median
-338% vs market
20202024
Return on equity
-482350300.0%
This company
18.4%
Market median
-2621469122% vs market
20202024
Net profit margin
-29.7%
This company
8.1%
Market median
-467% vs market
20202024
Asset turnover
3.17×
This company
1.12×
Market median
+183% vs market
20202024
Debt / equity
2.10×
This company
0.62×
Market median
-239% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HW Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Board of Directors | 2018 – 2022 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 | |
| Company | 49.48% | 49.48% | 2024 | |
| Individual | 8.35% | 8.35% | 2024 | |
| Individual | 8.35% | 8.35% | 2024 | |
Nasakkah S.A.R.L. | Company | 8.25% | 8.25% | 2024 |
| Company | 8.25% | 8.25% | 2024 | |
| Company | 4.12% | 4.12% | 2024 | |
| Company | 3.3% | 3.3% | 2024 | |
| Individual | 2.06% | 2.06% | 2024 | |
| Company | 2.06% | 2.06% | 2024 | |
| Company | 1.65% | 1.65% | 2024 | |
| Company | 1.65% | 1.65% | 2024 | |
| Company | 1.65% | 1.65% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AXONKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Håkon Weløy Aarseth | Chief Executive Officer | 0 companies |
| Ayman Samir Anis Rostom Yassa | Board of Directors | 0 companies |
| Øyvind Gjærevoll Schanke | Chairman | 0 companies |
| Anthony James Tennyson | Board of Directors | 0 companies |
| Silje Veen | Board of Directors | 0 companies |
| Nils Harald Thommessen | Board of Directors | 0 companies |
| Jonathan James Held | Board of Directors | 0 companies |